List of Tables
Table 1. Tianeptine Market Trends
Table 2. Tianeptine Market Drivers & Opportunity
Table 3. Tianeptine Market Challenges
Table 4. Tianeptine Market Restraints
Table 5. Global Tianeptine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Tianeptine Revenue Market Share by Company (2019-2024)
Table 7. Global Tianeptine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Tianeptine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Tianeptine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Tianeptine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Tianeptine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Tianeptine
Table 13. Global Tianeptine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tianeptine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Tianeptine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Tianeptine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Tianeptine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Tianeptine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Tianeptine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Tianeptine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Tianeptine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Tianeptine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Tianeptine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Tianeptine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Tianeptine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Tianeptine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Tianeptine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Tianeptine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Tianeptine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Tianeptine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Tianeptine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Tianeptine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Tianeptine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Tianeptine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Tianeptine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Tianeptine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Tianeptine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Tianeptine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Tianeptine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Tianeptine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Tianeptine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Tianeptine Sales Value by Region (2019-2024) & (%)
Table 44. Global Tianeptine Sales Value by Region (2025-2030) & (%)
Table 45. Global Tianeptine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Tianeptine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Tianeptine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Tianeptine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Tianeptine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Tianeptine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Tianeptine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Tianeptine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Tianeptine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Tianeptine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Tianeptine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Tianeptine Sales Volume, (2025-2030) & (K Units)
Table 57. Servier Company Information
Table 58. Servier Introduction and Business Overview
Table 59. Servier Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Servier Tianeptine Product Offerings
Table 61. Servier Recent Development
Table 62. Lupin Limited Company Information
Table 63. Lupin Limited Introduction and Business Overview
Table 64. Lupin Limited Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Lupin Limited Tianeptine Product Offerings
Table 66. Lupin Limited Recent Development
Table 67. PharmaS Company Information
Table 68. PharmaS Introduction and Business Overview
Table 69. PharmaS Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. PharmaS Tianeptine Product Offerings
Table 71. PharmaS Recent Development
Table 72. Antibiotice Company Information
Table 73. Antibiotice Introduction and Business Overview
Table 74. Antibiotice Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Antibiotice Tianeptine Product Offerings
Table 76. Antibiotice Recent Development
Table 77. Serdia Pharmaceuticals Company Information
Table 78. Serdia Pharmaceuticals Introduction and Business Overview
Table 79. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Serdia Pharmaceuticals Tianeptine Product Offerings
Table 81. Serdia Pharmaceuticals Recent Development
Table 82. Alvogen Company Information
Table 83. Alvogen Introduction and Business Overview
Table 84. Alvogen Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Alvogen Tianeptine Product Offerings
Table 86. Alvogen Recent Development
Table 87. Bausch Health Company Information
Table 88. Bausch Health Introduction and Business Overview
Table 89. Bausch Health Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Bausch Health Tianeptine Product Offerings
Table 91. Bausch Health Recent Development
Table 92. Genefar B.V. Company Information
Table 93. Genefar B.V. Introduction and Business Overview
Table 94. Genefar B.V. Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Genefar B.V. Tianeptine Product Offerings
Table 96. Genefar B.V. Recent Development
Table 97. Arena Pharmaceuticals Company Information
Table 98. Arena Pharmaceuticals Introduction and Business Overview
Table 99. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Arena Pharmaceuticals Tianeptine Product Offerings
Table 101. Arena Pharmaceuticals Recent Development
Table 102. Glenmark Company Information
Table 103. Glenmark Introduction and Business Overview
Table 104. Glenmark Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Glenmark Tianeptine Product Offerings
Table 106. Glenmark Recent Development
Table 107. Novartis Company Information
Table 108. Novartis Introduction and Business Overview
Table 109. Novartis Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Novartis Tianeptine Product Offerings
Table 111. Novartis Recent Development
Table 112. Dongwha Pharm Company Information
Table 113. Dongwha Pharm Introduction and Business Overview
Table 114. Dongwha Pharm Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Dongwha Pharm Tianeptine Product Offerings
Table 116. Dongwha Pharm Recent Development
Table 117. Liconsa SA Company Information
Table 118. Liconsa SA Introduction and Business Overview
Table 119. Liconsa SA Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Liconsa SA Tianeptine Product Offerings
Table 121. Liconsa SA Recent Development
Table 122. Mylan Company Information
Table 123. Mylan Introduction and Business Overview
Table 124. Mylan Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Mylan Tianeptine Product Offerings
Table 126. Mylan Recent Development
Table 127. Adamed Company Information
Table 128. Adamed Introduction and Business Overview
Table 129. Adamed Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Adamed Tianeptine Product Offerings
Table 131. Adamed Recent Development
Table 132. Neuraxpharm Arzneimittel Company Information
Table 133. Neuraxpharm Arzneimittel Introduction and Business Overview
Table 134. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Neuraxpharm Arzneimittel Tianeptine Product Offerings
Table 136. Neuraxpharm Arzneimittel Recent Development
Table 137. Grupo Insud Company Information
Table 138. Grupo Insud Introduction and Business Overview
Table 139. Grupo Insud Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Grupo Insud Tianeptine Product Offerings
Table 141. Grupo Insud Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Tianeptine Downstream Customers
Table 145. Tianeptine Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Tianeptine Product Picture
Figure 2. Global Tianeptine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tianeptine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Tianeptine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Tianeptine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Tianeptine Report Years Considered
Figure 7. Global Tianeptine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Tianeptine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tianeptine Revenue in 2023
Figure 10. Tianeptine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Patent Picture
Figure 12. Generic Picture
Figure 13. Global Tianeptine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Tianeptine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Tianeptine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Tianeptine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Tianeptine Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Depression and Anxiety
Figure 19. Product Picture of Irritable Bowel Syndrome
Figure 20. Global Tianeptine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Tianeptine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Tianeptine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Tianeptine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Tianeptine Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Tianeptine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Tianeptine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Tianeptine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Tianeptine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Tianeptine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Tianeptine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Tianeptine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Tianeptine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Tianeptine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Tianeptine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Tianeptine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Tianeptine Sales Volume (%), (2019-2030)
Figure 37. United States Tianeptine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Tianeptine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Tianeptine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Tianeptine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Tianeptine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Tianeptine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Tianeptine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Tianeptine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Tianeptine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Tianeptine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Tianeptine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Tianeptine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Tianeptine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Tianeptine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Tianeptine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Tianeptine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Tianeptine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Tianeptine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Tianeptine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Tianeptine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Tianeptine Sales Value by Application (%), 2023 VS 2030
Figure 58. Tianeptine Industrial Chain
Figure 59. Tianeptine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
